Oklahoma Supreme Court Overturns Opioid Ruling Against Johnson & Johnson


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


  • Oklahoma’s Supreme Court struck down a 2019 ruling against Johnson & Johnson (NYSE:JNJ) and overturned a $465 million fine, finding a judge incorrectly interpreted public nuisance laws.
  • The 5-to-1 decision that overturned the $465 million verdict issued by Cleveland County District Judge Thad Balkman in 2019 is a blow to the argument that companies that marketed, sold, and distributed opioids created a public nuisance.
  • Because J&J had appealed the previous ruling, none of the fines had been paid yet.
  • “In reaching this decision, we do not minimize the severity of the harm that thousands of Oklahoma citizens have suffered because of opioids,” the majority opinion wrote. “However grave the problem of opioid addiction is in Oklahoma, public nuisance law does not provide a remedy for this harm.”
  • The one dissenting judge, James E. Edmondson, said he disagreed with the ruling against J&J but thought that the decision should be remanded to the lower court.
  • Related Link: California Judge Rules For Drugmakers In Major Opioid Litigation.
  • Price Action: JNJ shares are up 0.82% at $163.84 during the market session on the last check Wednesday.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsHealth CareLegalGeneralBriefsopioid abuseOpioids